TNFRSF11A and prostate cancer: During the course of our experiments, we noticed that HNSCC cell lines expressed the RANKL receptor RANK (Fig. 4a) as abundantly as the PC3 and LNCaP cell lines from prostate cancer bone metastases, which are known to express this molecule28, 29.